The shares of Invesco Mortgage Capital Inc. (NYSE:IVR) started off the last trading session with the price of $16.43 while closing the day with the price of $16.57. The shares of Invesco Mortgage Capital Inc. (NYSE:IVR) Rise 1.22% with the Gain of 0.14 points.
The shares of Invesco Mortgage Capital Inc. (NYSE:IVR) traded with the day volume of 1.46 Million shares whereas its average trading volume is 1.43 Million.
While analyzing the past performance of the stock we can see that the shares of Invesco Mortgage Capital Inc. (NYSE:IVR) Gain 2.86% in the last week while rising 4.94% in the last month. Past quarter performance shows the red light with -9.7%. The semi-annual and annual performance shows -0.54% and 8.73% respectively.
Some critical values of the shares of Invesco Mortgage Capital Inc. (NYSE:IVR) to be discussed here are: the beta which shows the value at 0.75 while Average True Range of Invesco Mortgage Capital Inc. (NYSE:IVR) demonstrate the value at 0.31. The weekly and monthly volatility of the shares of Invesco Mortgage Capital Inc. (NYSE:IVR) are indicated at 1.42% and 1.97%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 57.33.
While studying the financial position of the shares of Invesco Mortgage Capital Inc. (NYSE:IVR), we can see that the Market capitalization of the company is at 1.85 Billion. The shares outstanding for the company is 111.62 Million and the shares float stands at 111.16 Million. The income of the company stand at 320.5 Million while the sales stand at 545.1 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.76, Price to Earnings or P/E is at 6, Price to Sales P/S show the value of 3.39, the Return on Asset ROA stood at 0.018 and the Return on Equity ROE depicted at 0.157 while Return on Investment ROI is at 0.017.
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA)
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) started its previous trading session at $17.85 and closed at $18.7 showing a Rise of 5.06 Percent.
The Company traded with an average Volume of 875 Million whereas, its Day Volume stood at 1.46 Million.
Looking at the performance of the stock, Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) Gain 1.08% in the last week in its shares price and 15.08% in the last month. Quarterly performance shows a green of 40.07 Percent while Semi-Annual and Annual performances shows a 7.78 and 35.02 percent respectively.
Beta for Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) stands at 1.72 while the ATR (average true range) is at 0.85. The Stock’s Weekly and Monthly Volatility is 4.59% and 4.55% respectively showing a RSI value of 65.08.
While studying the financial position of the shares of Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), we can see that the Market capitalization of the company is at 1.37 Billion. The shares outstanding for the company is 73.16 Million and the shares float stands at 71.76 Million.
The Company generated an income of -88100000 and the sales of 138.9 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.22 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 9.85 respectively.
The Return on Assets stands at -0.174, ROE shows a value of -0.236 and ROI for Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) is -0.247 as of Trailing Twelve Months period.
